The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Run-off Property-Liability; Protection Services; Allstate Health and Benefits; and Corporate and Other. The company offers private passenger auto, homeowners, personal lines, and commercial insurance products through agents, contact centers, and online; and property and casualty insurance products. It also provides consumer product protection plans, device and mobile data collection services, and analytic solutions using automotive telematics information, roadside assistance, and protection plans; and insurance products, such as identity protection and restoration through Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity, and Allstate Identity Protection brands. In addition, the company offers life, accident, critical illness, hospital indemnity, short-term disability, and other health insurance products; self-funded stop-loss and fully insured group health products to employers; medicare supplement, ancillary products, and short-term medical insurance to individuals through independent agents, owned agencies, benefits brokers, and Allstate exclusive agents. Further, it offers automotive protection; vehicle service contracts, guaranteed asset protection, road hazard tires and wheels, and paintless dent repair protection; and roadside assistance, mobility data collection services, and analytic solutions using automotive telematics information, identity theft protection, and remediation services. The Allstate Corporation was founded in 1931 and is headquartered in Northbrook, Illinois.

Allstate Corporation (The)

In a report released today, Paul Newsome from Piper Sandler maintained a Buy rating on Allstate, with a price target of $268.00. According to TipRa...

Piper Sandler Sticks to Their Buy Rating for Allstate (ALL)

Analysts have been eager to weigh in on the Financial sector with new ratings on IGM Financial (IGIFF) and Allstate (ALL). IGM Financial (IGIFF) In...

Analysts Conflicted on These Financial Names: IGM Financial (OtherIGIFF) and Allstate (ALL)

Citi analyst Adrian Lemme maintained a Buy rating on Aristocrat Leisure yesterday and set a price target of A$61.00. According to TipRanks, Lemme i...

Citi Sticks to Their Buy Rating for Aristocrat Leisure  (ARLUF)

In a report released on May 22, Elyse Greenspan from Wells Fargo maintained a Hold rating on Allstate, with a price target of $243.00. The company’...

Wells Fargo Remains a Hold on Allstate (ALL)

In a report released today, Alex Scott from Barclays maintained a Sell rating on Allstate, with a price target of $208.00. Scott covers the Financi...

Allstate (ALL) Receives a Sell from Barclays

Using the TipRanks Stock Screener Tool, we identified three companies that have low Price-to-Earnings (P/E) ratios and hold a “Strong Buy” consensu...

3 ‘Strong Buy’ Low P/E Stocks with Over 20% Upside

Allstate ( ($ALL) ) just unveiled an announcement. Allstate disclosed that its April 2026 monthly release, which provides estimates of catastrophe ...

Allstate Posts April Catastrophe Loss and Policy Update

In a report released today, Michael Roxland from Truist Financial reiterated a Buy rating on Ball, with a price target of $77.00. According to TipR...

Ball (BALL) Receives a Buy from Truist Financial

In a report released on May 15, Owen Paterson from Jefferies maintained a Hold rating on Ayvens SA, with a price target of €11.00. The company’s sh...

Jefferies Sticks to Its Hold Rating for Ayvens SA (3AL)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Allogene Therapeutics (ALLO), Evommune, Inc. (EVMN) ...

Analysts’ Top Healthcare Picks: Allogene Therapeutics (ALLO), Evommune, Inc. (EVMN)

Ord Minnett analyst maintained a Buy rating on Aristocrat Leisure today and set a price target of A$61.00. In a report released today, UBS also mai...

Ord Minnett Reaffirms Their Buy Rating on Aristocrat Leisure  (ARLUF)

Morgans analyst Leo Partridge maintained a Buy rating on Aristocrat Leisure today and set a price target of A$67.00. Partridge covers the Consumer ...

Morgans Sticks to Their Buy Rating for Aristocrat Leisure  (ARLUF)

Allot Communications (($ALLT)) has held its Q1 earnings call. Read on for the main highlights of the call. Allot Communications’ latest earnings ca...

Allot Communications Earnings Call Highlights SECaaS Surge

In a report released today, Adrian Lemme from Citi maintained a Buy rating on Aristocrat Leisure , with a price target of A$65.00. According to Tip...

Allarity Therapeutics ( ($ALLR) ) just unveiled an announcement. Allarity Therapeutics said it will begin using a new corporate presentation with i...

Allarity Highlights Stenoparib Progress in New Investor Presentation

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Trigano SA (TGNOF), Versigent Limited (VGNT) and Ball (BAL...

Analysts Offer Insights on Consumer Cyclical Companies: Trigano SA (OtherTGNOF), Versigent Limited (VGNT) and Ball (BALL)

In a report released today, Meyer Shields from KBW maintained a Buy rating on Allstate, with a price target of $266.00. Shields covers the Financia...

KBW Keeps Their Buy Rating on Allstate (ALL)

Value stocks are shares of companies that appear undervalued relative to their fundamentals. This means their stock price looks low compared with w...

3 Best Value Stocks to Buy in May 2026, According to Analysts 

Analysts have been eager to weigh in on the Financial sector with new ratings on Moelis (MC), First Interstate Bancsystem (FIBK) and Allstate (ALL)...

Analysts Have Conflicting Sentiments on These Financial Companies: Moelis (MC), First Interstate Bancsystem (FIBK) and Allstate (ALL)

Analysts fell to the sidelines weighing in on MARA Holdings (MARA) and Allstate (ALL) with neutral ratings, indicating that the experts are neither...

Analysts Are Neutral on These Financial Stocks: MARA Holdings (MARA), Allstate (ALL)

Analysts fell to the sidelines weighing in on Allstate (ALL) and Moelis (MC) with neutral ratings, indicating that the experts are neither bullish ...

Analysts Offer Insights on Financial Companies: Allstate (ALL) and Moelis (MC)

An announcement from Ball ( ($BALL) ) is now available. At its April 29, 2026 annual meeting of shareholders, Ball’s investors approved the company...

Ball Shareholders Approve Directors, Pay and Incentive Plan

Alleima AB ( ($SE:ALLEI) ) just unveiled an update. Alleima AB’s 2026 Annual General Meeting in Sandviken approved the 2025 accounts, discharged th...

Alleima AGM Approves Dividend, New Incentive Plan and Share Buyback Mandate

In a report released today, Alexander Virgo from Evercore ISI maintained a Buy rating on Allegion, with a price target of $175.00. According to Tip...

Evercore ISI Sticks to Their Buy Rating for Allegion (ALLE)

UBS analyst Haley Tam maintained a Hold rating on Allfunds Group plc today and set a price target of €9.25. Tam covers the Financial sector, focusi...

Allfunds Group plc (6UY) Gets a Hold from UBS

UBS analyst Andre Fromyhr maintained a Buy rating on Aristocrat Leisure today and set a price target of A$68.90. Fromyhr covers the Industrials sec...

UBS Sticks to Its Buy Rating for Aristocrat Leisure  (ARLUF)

SoFi Technologies ($SOFI) is entering what could be its most important earnings moment yet, as the company looks to prove its transition from a los...

SoFi (SOFI) Signals a Real Shift toward Profitability. Now Earnings Need to Confirm It

Morgan Stanley analyst Melinda Baxter maintained a Buy rating on Aristocrat Leisure on April 24 and set a price target of A$59.80. The company’s sh...

Market Cap	$50.91B	P/E Ratio	7.27
52W High	$227.62	52W Low	$188.08
Div Yield	432.0%	Payout Ratio	6.6%
EPS Growth 3Y	N/A	52W Position	62.6%
Overall Score	62	Value Score	80
Quality Score	47	Technical Score	60

EPS Current Est	$29.28	EPS Next Est	$26.49
EPS Growth Est	-9.5%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ALL	$212.82	-1.75%	1.30M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ALL	$212.82	-1.7%	1.30M
3
4
5
6

ALL

ALL

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Allstate Corporation (The) Data in Excel

Get Allstate Corporation (The) Data in Excel